e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets
N. Ishikawa, N. Hattori, M. Taniwaki, Y. Horimasu, T. Matsuda, N. Kohno (Hiroshima, Japan)
Source:
Annual Congress 2012 - Idiopathic pulmonary fibrosis
Session:
Idiopathic pulmonary fibrosis
Session type:
Poster Discussion
Number:
3147
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Ishikawa, N. Hattori, M. Taniwaki, Y. Horimasu, T. Matsuda, N. Kohno (Hiroshima, Japan). Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets. Eur Respir J 2012; 40: Suppl. 56, 3147
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Gene expression profiling: can we identify the right target genes?
Source: Eur Respir Rev 2008; 17: 163-167
Year: 2008
A novel prognostic signature based on five-immune-related genes for idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Gene expression profiling: identifying novel gene targets for therapeutic intervention
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies
Source: Eur Respir J, 53 (3) 1900283; 10.1183/13993003.00283-2019
Year: 2019
Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis?
Source: Eur Respir J 2016; 48: 1271-1273
Year: 2016
Gene expression profiling identifies neutrophilic and eosinophilic asthma as distinct subtypes
Source: Eur Respir J 2007; 30: Suppl. 51, 526s
Year: 2007
Different expression profiles of gelsolin in various types of idiopathic interstitial pneumonias (IIPs). A tissue microarray study
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Validation of a novel prognostic tool for idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Micro Array screening of microRNA markers of interstitial lung diseases for differential diagnostics.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
Source: Eur Respir J 2006; 28: Suppl. 50, 152s
Year: 2006
Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension – Novel therapeutic targets
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept